let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non–small–cell lung cancer E Jusufović, M Rijavec, D Keser, P Korošec, E Sodja, E Iljazović, ... Public Library of Science 7 (9), e45577, 2012 | 123 | 2012 |
Alpha-lipoic acid reduces body weight and regulates triglycerides in obese patients with diabetes mellitus. A Okanović, B Prnjavorac, E Jusufović, R Sejdinović Medicinski Glasnik 12 (2), 2015 | 50 | 2015 |
" Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for Asthma M Al-Ahmad, N Arifhodzic, J Nurkic, A Maher, T Rodriguez-Bouza, ... Medical Principles and Practice 27 (3), 260-266, 2018 | 24 | 2018 |
Association of molds and metrological parameters to frequency of severe asthma exacerbation M Al-Ahmad, E Jusufovic, N Arifhodzic, T Rodriguez, J Nurkic Allergy, Asthma & Clinical Immunology 15, 1-9, 2019 | 20 | 2019 |
Sensitization to cat: when is nasal challenge needed? M Al-Ahmad, E Jusufovic, N Arifhodzic, J Nurkic, AL Hanoun International Archives of Allergy and Immunology 179 (2), 108-113, 2019 | 16 | 2019 |
Chest x-ray resolution after SARS-CoV-2 infection. B Prnjavorac, A Mujaković, L Prnjavorac, T Bego, E Jusufović, E Begić, ... Medicinski Glasnik 18 (2), 2021 | 10 | 2021 |
Drug allergy profile from a national drug allergy registry M Al-Ahmad, J Edin, F Musa, T Rodriguez-Bouza Frontiers in Pharmacology 11, 555666, 2021 | 10 | 2021 |
The role of target organ diagnostic approach in seasonal allergic rhinitis: nasal smear eosinophils J Nurkic, M Al Ahmad, N Arifhodzic, E Jusufovic Materia socio-medica 28 (2), 125, 2016 | 10 | 2016 |
Tolerability of omalizumab in asthma as a major compliance factor: 10-year follow up M Al-Ahmad, J Nurkic, A Maher, N Arifhodzic, E Jusufovic Open Access Macedonian Journal of Medical Sciences 6 (10), 1839, 2018 | 8 | 2018 |
Curcumin as an add-on therapy of moderate partially controlled asthma E Jusufovic, M Kosnik, A Jusufovic, M Becarevic, M Al-Ahmad, J Nurkic, ... Eur Respir J 50, 442, 2017 | 7 | 2017 |
Role of nasal challenge and local eosinophilia in indirect exposure to cat in allergic rhinitis patients M Al Ahmad, N Arifhodzic, J Nurkic, E Jusufovic, AL Hanoun, T Rodriguez Eur Ann Allergy Clin Immunol 50 (3), 125-31, 2018 | 6 | 2018 |
Most common, real life factors affecting effectiveness of omalizumab asthma treatment: a 10-year study. J Nurkić, M Al-Ahmad, A Maher, N Arifhodžić, E Jusufović Medicinski Glasnik 16 (1), 2019 | 5 | 2019 |
Local CD4+, CD8+ and CD56+ T-lymphocite reaction on primary lung cancer E Jusufovic, B Prnjavorac, E Iljazovic, M Kosnik, D Keser, P Korosec, ... Acta Informatica Medica 19 (3), 132, 2011 | 5 | 2011 |
Local CD4+, CD8+ and CD56+ reactions to lung cancer in re-gard to pathohistological type and clinical stage E Jusufovic, E Iljazovic, M Kosnik, D Keser, P Korosec, E Zukic, ... Official Publication of the Medical Association of Zenica-Doboj Canton …, 2011 | 5 | 2011 |
Severe asthma in Kuwait population: Phenotype-based approach M Al-Ahmad, J Nurkic, Y Othman, E Jusufovic, A Maher Respiratory Medicine 187, 106586, 2021 | 4 | 2021 |
Early predictors of severity and mortality in COVID-19 hospitalized patients. S Mustafić, E Jusufović, F Hukić, E Trnačević, A Divković, A Trnačević Medicinski Glasnik 18 (2), 2021 | 4 | 2021 |
Curcumin improves step 4 asthma treatment: placebo-controlled, single blind study J Edin, K Mitja, A Nermina, N Jasmina, M Al-Ahmad Pulm Resp Med Int J 2 (1), 5-9, 2019 | 4 | 2019 |
Downregulated anti-angiogenic miR-19a, miR-126 and let-7b in non-small lung cancer have poor but different prognostic values in squamous and adenocarcinoma subtypes E Jusufovic, D Keser, E Zukic, R Sejdinovic, D Mrsic European Respiratory Journal 42 (Suppl 57), 2013 | 4 | 2013 |
Which skin prick test wheal size detects true allergy to Salsola kali? M Al-Ahmad, E Jusufovic, N Arifhodzic European Annals of Allergy and Clinical Immunology 53 (5), 228-233, 2020 | 3 | 2020 |
Hot Topics of Tobacco Control in Bosnia and Herzegovina E Jusufovic Tobacco Prevention & Cessation 4 (Supplement), 2018 | 3 | 2018 |